Archive for May, 2010
-
The Lloyd and Charlie Show
Eddy Elfenbein, May 3rd, 2010 at 1:59 pmLloyd Blankfein sits down to chat with Charlie Rose (this video is 51 minutes).
-
S&P 500 Total Return Index
Eddy Elfenbein, May 3rd, 2010 at 12:49 pmHere’s a look at the S&P 500’s Total Return Index which includes reinvested dividends:
Even after an impressive rally, we’re still below where we were 10 years ago. Inflation, or at least the official measures of inflation, show that prices are up close to 30% from 10 years ago. -
January 2011 $2.50 Goldman Sachs Puts
Eddy Elfenbein, May 3rd, 2010 at 11:09 amTimothy Collins reports:
In case anyone is interested, the January 2011 $2.50 Goldman Sachs puts – yes, $2.50 puts — are trading at 2 cents by 3 cents.
Hmmm. I’ll wait and see.
-
Buffett Talks Business
Eddy Elfenbein, May 3rd, 2010 at 10:44 am
(Via: Ritholtz) -
ISM Index Rises to 60.4
Eddy Elfenbein, May 3rd, 2010 at 10:30 amOne of my favorite economic indexes is the Institute for Supply Management’s Index. The latest number was just released and it was another very good report:
Conditions for the nation’s manufacturers improved again in April to its highest level since June 2004, the Institute for Supply Management reported Monday. The ISM index jumped to 60.4% in April from 59.6% in March. This is above forecasts. The consensus forecast of estimates collected by MarketWatch was for the index to rise to 60.1%. Readings above 50 indicate expansion. New orders were strong in April and the employment index improved again. Seventeen of 18 industries reported growth in April.
The ISM comes out on the first business day of each month which makes it far more timely than many other economic indicators. Any number above 50 means the economy is growing. Below 50 means it’s contracting.
Historically, the ISM has a very good track record of pinpointing recessions.
I’m still in the camp that thinks the Fed will raise rates — perhaps not soon, but sooner than most people expect. -
Sysco Has Turned the Corner
Eddy Elfenbein, May 3rd, 2010 at 10:17 amOur Buy List is very nearly done with this earnings season. Today, Sysco (SYY) reported earnings for its fiscal third quarter of 42 cents a share. This was two cents better than Wall Street’s estimates. This was the fourth straight quarter that Sysco has topped expectations. The stock opened higher but has since pulled back and is now down slightly.
Bill DeLaney, Sysco’s CEO said, “The underlying business environment appears to be improving, as evidenced by both the case volume growth and easing of deflation that we realized as the quarter progressed.”
This is a key point. Sysco has been sharply impacted by lower prices. They’ve responded by cutting overheard (meaning jobs and pay), but this past quarter is the first one since September 2008 that showed growing year-over-year sales. This is how good companies manage their way through recessions. Sysco is a good example of a company that has met its challenges but it hasn’t yet been rewarded by investors.
For this fiscal year (ending in June), Sysco should make about $1.95 per share, and probably about $2.10 per share next year. Sysco currently pays a nice dividend which yields 3.2%. Given Sysco’s current price, the stock is a decent buy.
The one remaining Buy List stock to report earnings is little Nicholas Financial (NICK). I’m a big fan of NICK and I think it’s an outstanding buy. I’ll have more on NICK later this week.
-
How the Toxic Assets Were Magnified
Eddy Elfenbein, May 3rd, 2010 at 9:28 amOne of the interesting aspects of the financial crisis is how a relatively small sector of the mortgage housing market — subprime — was able to infect the entire financial system. The WSJ has a very good article explaining how this was done (warning, it’s a little on the wonky side):
In a memo last week, panel Chairman Sen. Carl Levin (D., Mich.) said Goldman’s work “magnified the impact of toxic mortgages” by replicating mortgage securities in debt pools known as collateralized debt obligations as well as CDO derivatives, and also in an index that tracks subprime bonds.
The subprime mortgages that caused big losses generally were packaged into CDOs, in which dozens of mortgage-backed bonds were pooled together and slices of the CDOs were sold to investors. Another version of these CDOs didn’t contain actual mortgage bonds but were linked to them via derivatives called credit-default swaps. Through the use of derivatives, banks created many of these synthetic CDOs using the same mortgage securities, all of which would rise or fall in value depending on how the mortgages were performing. With synthetic CDOs, those who had bet that the loans would perform well were on the hook if their performance deteriorated.
In effect, the documents said, Wall Street was “copying and pasting” what turned out to be the worst-performing securities of the mortgage boom. Such activity helped multiply opportunities for hedge funds and traders who wanted to short the housing market, but magnified the losses of those on the other side of the trades. To short a trade, in this instance, is to bet the housing market will turn down.In the Washington Post, Heidi Moore takes on the silly notion that only sophisticated were hurt:
It’s not just the big clients, however, that get hurt. What Wall Street would like to ignore when it is taking bets in its casino is that a big pile of chips on the table come from regular consumers — from their bank deposits, retirement accounts, credit-card balances, car loans and mortgages. That’s why the distinction between these sophisticated investors and everyone else is nonexistent. When Wall Street banks omit information and draw profits from “institutional investors,” that means they are taking money from your pension funds, your school endowments, and your city and state governments. Other sophisticated investors include hedge funds, which take money from those pension funds, or private-equity funds, which own companies that employ 10 percent of all Americans.
Pension funds, for instance, are considered “sophisticated investors” on Wall Street. But those are just pools of retirement money owed to workers. The pension funds, looking to expand their stash, invest in stocks and bonds sold by Wall Street. These pension funds also give their money to other funds, such as hedge funds and private equity funds, that invest that money in riskier investments, perhaps troubled companies or distressed mortgages. Pension funds play the Wall Street game to score a healthy return — but when they lose, the money lost belongs to regular people. -
Weekend Poll
Eddy Elfenbein, May 1st, 2010 at 5:15 pmIn honor of May Day, here’s a weekend tax poll:
-
Barron’s on Johnson & Johnson
Eddy Elfenbein, May 1st, 2010 at 5:07 pmBarron’s gives some love to one of my favorite Buy List stocks, Johnson & Johnson (JNJ). Here’s an excerpt:
One of the health-care giant’s biggest virtues is its prodigious ability to generate cash. That has helped keep its debt load low. Johnson & Johnson is one of just four U.S. industrial companies with a coveted AAA rating from Standard & Poor’s. (The others: Automatic Data Processing, Exxon Mobil and Microsoft.) At the end of 2009, the company had about $14 billion in debt, compared with shareholder’s equity of $50.6 billion. Cash flow from operations came to $16.6 billion last year, up from about $15 billion in 2008. Cash and equivalents weighed in at $15.8 billion on Dec. 31.
The company is devoting some of its cash to its quarterly dividend, which it boosted 10.2% last month, from 49 cents a share to 54 cents — marking the 48th straight annual payout increase. At $2.16 a year, the yield is a very healthy 3.3%. Bill McMahon, president of ThomasPartners, an investment advisory firm in Wellesley, Mass., with a stake in the company, says consistent dividend increases are “a good directional signal of future returns.”
Another priority is buying back stock. In 2007, the board authorized the repurchase of as much as $10 billion in shares; $9 billion worth has been reacquired so far.
The cash hoard also helps Johnson & Johnson to buy companies, typically for $1 billion or less, to expand its product lines or get into new ones. For example, J&J paid $1 billion last July for an 18.4% equity stake in the biotech company Elan (ELN). In exchange, it got access to substantially all of Elan’s anti-Alzheimer’s products, including bapineuzumab, a promising drug now in Phase III trials.
In its quest to come up with new products, Johnson & Johnson pumped nearly $7 billion into R&D last year, even as it was restructuring its operations, an action expected to trim up to $1.7 billion in annual pretax costs. The company has intensified its effort to fatten its margins, which slid in recent years as patents expired on highly profitable prescription drugs. An encouraging sign: In the first quarter, selling, marketing and administrative expenses equalled 30.5% of sales, down from 30.7% a year earlier.
-
-
Archives
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005